您的购物车当前为空
DL-AP7 是一种竞争性NMDA 拮抗剂和抗惊厥剂。DL-AP7 阻断 NMDA 诱导的惊厥,并导致小鼠在被动回避任务中的学习表现受损。

DL-AP7 是一种竞争性NMDA 拮抗剂和抗惊厥剂。DL-AP7 阻断 NMDA 诱导的惊厥,并导致小鼠在被动回避任务中的学习表现受损。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 4-6周 | |
| 50 mg | ¥ 13,800 | 4-6周 | |
| 100 mg | ¥ 17,500 | 4-6周 |
DL-AP7 相关产品
| 产品描述 | DL-AP7, a competitive NMDA antagonist and anticonvulsant, blocks NMDA-induced convulsions and impairs learning performance in mice during a passive avoidance task [1]. |
| 体内活性 | DL-AP7 (Administration: ICV) blocks the NMDA-induced convulsions (ED 50 =0.22 nmol/mouse) and impairs learning performance in a passive avoidance task in mice [1]. |
| 分子量 | 225.18 |
| 分子式 | C7H16NO5P |
| CAS No. | 85797-13-3 |
| 密度 | 1.39 g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | 1eq. NaOH: 100 mM, Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
1eq. NaOH
| ||||||||||||||||||||||||||||||||||||
评论内容